Services Overview

We act as your agent, representative, interim or mentor/coach. We can set up your company in Japan. We are dedicated to making your commercial success real!

We supply the market intelligence you need to be successful in Japan!

We connect you with the right Japanese companies within Biopharma, ATMP, CGT, Regenerative Medicine, Pharmaceuticals, Combination Devices, IVD’s, Universities and distributors. The right mix you need among: Trade Shows, KOLs, customers, partners, distributors . . .

A handshake under the Rising Sun of Japan.

Biosector = Commercialization in Japan

Preparation and reports – What you need to know!

We produce your feasibility studies and all other types of reports that you need to unlock your commercial pathway into Japan’s Pharmaceutical Industry. We help pave every step of your commercialization process.

Download for free:

  1. Our comprehensive guide: Checklist: How to best prepare for your next tradeshow in Japan
  2. Our Basic Guide: Japanese business culture – and you!

You need: fast, accurate and actionable reports, feasibility studies, target lists and analysis to be able to draw up the best strategies.

We supply: just that!

By partnering with Biosector, you get the upper hand!

Market Entry: Seamless Integration and Strategic Positioning

Your success in Japan requires the following keys:

  1. Budget
  2. Cultural competence
  3. Clear goals
  4. Strategic approach
  5. Feet on the ground
  6. Long term mindset
  7. Patience
  8. Consistency


We make sure you are moving as fast as possible and that your expectations are aligned with those of your future clients and partners’ in Japan.

Market Expansion: Optimizing Your New Commercial Opportunities and Accelerating Growth

Expanding your footprint in Japan is crucial. Accelerating your growth successfully equals long-term success. You need competence and excellence: we supply! You need to optimize your new avenues for growth – we support you! We assist you in making sure of your new market segments and their strategies.

Leveraging your opportunities through our extensive industry connections is a valuable shortcut.

With Biosector, you have the advantage that only comes with exceptional professionals. Every step of the way.

About Stefan Sandström 

CEO of Biosector Ltd. Residence

Residence: Based in Metropolitan Tokyo since 2007.

Unique Perspective: Science and business.

Education: Medicine and chemical engineering.

Leadership: Successfully led multiple industrial companies as CEO.

Accreditations: Accredited business consultant via  German RKW.

Collaborations: Japanese partner to notable entities:  SPECTARIS and Kalms Consulting.

Recognitions: Appointed as an expert on conducting business in Japan by the EU-Japan Centre for Industrial Cooperation.

Track Record: Three decades of experience in international and cross-border business development, achieving first sales.

Passion: Kendo (martial art) with the rank of 6 dan.

Testimonials/Cases

Dan Spacie

CEO of MAP Patient Access, UK

”I have worked with Stefan Sandström outside of Biosector for over a year and will continue to work with him in Biosector. This is an exceptionally highly skilled partner, walking the extra mile and having made all the difference for building our traction in Japan.”

Anne-Kathrin Schmalz

Senior Manager Foreign Trade and Export Promotion

”Mr Sandström delivered an amazing seminar for our members in Sep 2021. He combined extensive specialist knowledge of the Japanese bio and laboratory market and how to bridge cultural differences. ”

Tony White

“Biosector’s business intelligence has helped me identify investment opportunities I would never have discovered. They deliver incisive analysis applying the Pareto Principle, allowing me to make fast decisions and save huge amounts of time. A great help for guiding the next steps forward.” – Tony White, founder of BioPhorum and angel investor

Blog

A vibrant night scene of a futuristic cityscape in Japan with skyscrapers illuminated by neon lights, featuring a bustling street with diverse pedestrians and holographic signs.
Japan presents a unique landscape for pharmaceutical companies, both domestic and international. The recent study published in Therapeutic Innovation & Regulatory Science sheds light on the disparities in drug development strategies between Japan-based and foreign-based companies, revealing substantial implications for strategic business development. URL: https://pubmed.ncbi.nlm.nih.gov/38575785/  Strategic […]
Wide-format illustration depicting ISO 13485's impact on the medical device industry, with navy blue, sand, and pink colors, featuring medical devices, ISO certification logo, and subtle Japanese elements like cherry blossoms and Mount Fuji silhouette.
The medical device industry demands the highest standards of quality and safety for its poducts. ISO 13485 saves lives as it’s a crucial guideline for manufacturers worldwide. This standard outlines a comprehensive QMS for the entire lifecycle of medical devices. The lifecycle begins with design and […]
An illustration blending Japanese tradition with the futuristic vision of Society 5.0, featuring a digital human silhouette, Mount Fuji, a robotic arm, a cherry blossom branch with tech motifs, and a torii gate transitioning into digital code, set against a classic Japanese pattern in blue.
In this rapidly advancing era, the concept of Society 5.0 has emerged as a driving force in Japan’s aspirations for the future. Society 5.0 is characterized as a human-centered society that harmoniously integrates cyberspace and physical space, resolving social challenges while fostering economic development. In this […]
An illustration featuring a central origami figure in gold, symbolizing the concept of 'Software as a Medical Device' (SaMD) against a minimalistic background. The design merges technology and healthcare through an elegant origami representation.
Overview:  Introduction Six-month review process priority registration expanded PMDA support innovative drug consultation early application feedback Introduction Japan’s SaMD and PMDA regulatory framework has evolved quite a lot! From a pragmatic POV, there has been a significant shift towards improving the Japanese registration process’s speed and […]
An artistic graphic showing an overview of the Marketing Authorization Holder (MAH) system in Japan with icons representing approval processes, quality assurance, and post-marketing surveillance.
Understanding the MAH Japan System In Japan, the Marketing Authorization Holder (MAH) is central in the pharmaceutical and medical device sectors. An MAH is tasked with securing marketing approval for products, overseeing manufacturing processes, ensuring product quality, and conducting post-marketing surveillance. The MAH system in Japan […]
This compelling photo-realistic collage visually narrates the innovative process of TIL therapy in cancer treatment. It begins with the extraction of immune cells from a tumor, depicted on the left with a detailed image of a cancerous mass. The focus then shifts to the center, where a laboratory environment is shown, symbolizing the critical phase of cell expansion. Finally, on the right, the reinfusion of these cells into a patient is portrayed, completing the therapeutic cycle. Each step is vividly illustrated, providing a comprehensive understanding of TIL therapy's potential to transform cancer care. This image serves as an educational and engaging visual aid for professionals and enthusiasts in the fields of oncology, immunotherapy, and medical research.
In the dynamic and ever-evolving field of oncology, Tumor-Infiltrating Lymphocytes (TILs) represent the latest in innovation and hope. This blog post captures how TIL Therapy is doing in the Japanese Biopharma ecosystem. We are looking at Japan’s pharmaceutical and biopharma industries, highlighting the potential to revolutionize […]

Please feel warmly welcome to contact us:

email: info@biosector.jp
phone: +81 80-3404-8431

Address: Yokohama Landmark Tower, 20th Floor, 2-2-1 Minatomirai, Nishi-ku, 〒220-8120,

Yokohama, JAPAN

Deliveries: Kosugaya 1-20-6-202, Sakae-ku, 〒247-0007, Yokohama, JAPAN

© 2023-24 Biosector Ltd.